$X4 Pharmaceuticals(XFOR.US)$ FDA Approves X4 Pharmaceuticals' Xolremdi (Mavorixafor) Capsules For Use In Patients 12 Years Of Age And Older With WHIM Syndrome To Increase The Number Of Circulating Mature Neutrophils And Lymphocytes

$X4 Pharmaceuticals(XFOR.US)$ But remember April 30 is PDUFA day at FDA! Hehehe Yes it rhymes thats why i said it that way!

📌Last week’s PDUFAs:
$Heron Therapeutics(HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia(LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies(THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$Sanofi(SNY.US)$ & $Regeneron Pharmaceuticals(REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...

$Heron Therapeutics(HRTX.US)$ Just now at 3:20 PM est i checked and this is still listed as pending on FDA schedule for answer today 1/23/24

$Heron Therapeutics(HRTX.US)$ Just peeking at the FDA calendar as of 2:35PM est today 1/22/24. And its still listed for tomorrow!

$Heron Therapeutics(HRTX.US)$ uptrending straight 6 days more upside potential buying some here ! lfg

$PDS Biotechnology(PDSB.US)$$PDSB $PDSB JUST ANNOUNCED 75% CANCER SURVIVAL RATE KABOOM STAMP 11/9/23 721AM